News

Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

The Department of Psychiatry and Behavioral Sciences ranked ninth in the country for NIH funding in 2023.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Two MUSC researchers think that community libraries could hold the potential to improve head and neck cancer awareness.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.

South Carolinians interested in cancer survivorship - as providers, researchers, caregivers or survivors - are invited to the first SCOR symposium in June.

MUSC researchers find differences in young adults’ experience of cannabis and risk for cannabis use disorder based on genetics and sex.